PZA and cytochrome Bc1 inhibitor combination treatment
US11918575B2 · kind B2 · utility
0Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2021 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | Feb 11, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel combinations, which are useful in the treatment of tuberculosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.